Fengjiao Hu

发表

The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin‐Mediated Degradation of 3‐Hydroxy‐3‐Methylglutaryl CoA Reductase Degradation Protein 1

Hongliang Li, Yufeng Yuan, Zhi‐Gang She, 2021, Hepatology.

FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway.

Jia Liu, Shuyan Li, Yang Yang, 2020, Journal of molecular and cellular cardiology.

Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis

R. Touyz, Hongliang Li, Jingjing Cai, 2021, Science Translational Medicine.

The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy

Jingjing Cai, P. Zhang, Zhi‐Gang She, 2022, Circulation research.

N‐acetylgalactosaminyltransferase‐4 protects against hepatic ischemia/reperfusion injury by blocking apoptosis signal‐regulating kinase 1 N‐terminal dimerization

Li Zhang, S. Tian, Junjie Zhou, 2021, Hepatology.

Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD

Hongliang Li, Zan Huang, Jie Yu, 2021, Hepatology.

Ca 2+ dependent-NOX5 exaggerates cardiac hypertrophy through ROS production

R. Touyz, A. Montezano, P. Zhang, 2021 .

Ca2+-Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production

R. Touyz, Hongliang Li, A. Montezano, 2020, Hypertension.

Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling.

Guizhi Yang, Jiao Guo, S. Tian, 2021, Journal of hepatology.

Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy

Hongliang Li, Chongshu Jian, Zhi‐Gang She, 2020, Bioscience reports.

Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD

Hongliang Li, Zhi‐Gang She, Xu Cheng, 2021, Hepatology.

TNFAIP3 Interacting Protein 3 Is an Activator of Hippo‐YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury

Hongliang Li, Zhi‐Gang She, Xu Cheng, 2021, Hepatology.

TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic disease.

Hongliang Li, Yufeng Yuan, Zhi‐Gang She, 2021, Cell metabolism.

FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP‐activated protein kinase–Caspase 6 signal axis

Jie Zhou, Xiaokun Li, Qiong Chen, 2022, Hepatology.

The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin‐Mediated Degradation of 3‐Hydroxy‐3‐Methylglutaryl CoA Reductase Degradation Protein 1

Hongliang Li, Yufeng Yuan, Zhi‐Gang She, 2021, Hepatology.

Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progression

Zhi‐Gang She, Xiao-Jing Zhang, Xin Zhang, 2024, Science Translational Medicine.

SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner

Qiaofeng Qian, Yang Li, Hongjie Shi, 2023, Journal of the American Heart Association.